Print Page  |  Close Window

Overview

Corporate Profile

LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care. LabCorp reported net revenues of nearly $9.5 billion ... Read More >>

Recent News

01/19/18

LabCorp Named to FORTUNE Magazine's 2018 List of ‘World’s Most Admired Companies’

01/08/18

Covance Introduces Dedicated Offering Designed for Biotech, Medical Device and Diagnostics Companies

01/03/18

LabCorp is Scheduled to Present at the 36th Annual J.P. Morgan Healthcare Conference

Upcoming Events

Tuesday, February 6, 2018 9:00 a.m. ET

Q4 2017 Laboratory Corporation of America Holdings Earnings Conference Call

Tuesday, February 27, 2018

LabCorp Investor & Analyst Day, New York, NY

LH (Common)
ExchangeNYSE
Price$174.39
Change Stock is Up 1.28
Data as of 01/19/18 4:02 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.